Latest News

Wednesday, November 26, 2014 | Earnings & Financials, Valeant Ophthalmics

After Failed Takeover Attempt, Valeant Announces $2 Billion Buyback

Valeant Pharmaceuticals International said it plans to buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it had bought back no securities. The compan…

Read the full story

Wednesday, November 26, 2014 | Miscellaneous

Mitosol Awarded National Supply Agreement with HealthTrust

Mobius Therapeutics has been awarded a supply agreement for Mitosol (mitomycin for solution) Kit for ophthalmic use from HealthTrust, according to a company news release. Effective November 1, 2014, M…

Read the full story

Wednesday, November 26, 2014 | Miscellaneous

2014 American Academy of Optometry Reaches Largest Attendance to Date

Academy 2014 Denver was the 93rd annual meeting of the American Academy of Optometry, and the largest meeting in Academy history with 6,323 total registrants. This included 3,858 optometrists and visi…

Read the full story

Wednesday, November 26, 2014 |

New Insight Into Age-Related Macular Degeneration

Scientists at The University of Manchester have identified an important new factor behind one of the major causes of blindness, which they hope could lead to new treatments. Age-related Macular Degene…

Read the full story

Wednesday, November 26, 2014 | Medical Studies

Study Shows How Brain Maps Develop to Help Us Perceive the World

Driving to work becomes routine--but could you drive the entire way in reverse gear? Humans, like many animals, are accustomed to seeing objects pass behind us as we go forward. Moving backwards feels…

Read the full story

Tuesday, November 25, 2014 | Earnings & Financials

Eleven Biotherapeutics Announces Additional Financing of $20 Million

Eleven Biotherapeutics announced that it has entered into a securities purchase agreement for the sale of $20 million of Eleven Biotherapeutics common stock and warrants in a private placement financi…

Read the full story

Tuesday, November 25, 2014 | Clinical Trials

R-Tech Ueno Receives Orphan Drug Designation in Japan for Unoprostone Isopropyl (UF-021) for the Treatment of Retinitis Pigmentosa

R-Tech Ueno announced that it has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) for Unoprostone Isopropyl (Unoprostone, development code: UF-021) for the trea…

Read the full story

Tuesday, November 25, 2014 | Medical Studies

Blinking Exercises Help Ease Evaporative Dry Eye

In patients with evaporative dry eye, blinking exercises can help decrease partial blinking and improve meibomian gland function and symptoms, according to a new study. Detecting and quantifying parti…

Read the full story

Tuesday, November 25, 2014 | Medical Studies

Office Test Overestimates Eye's Ability to Change Focus in Preschoolers

In preschool-aged children, a simple test performed in the ophthalmologist's or optometrist's office greatly overestimates the eye's ability to "flex and focus" in order to see s…

Read the full story

Monday, November 24, 2014 | Miscellaneous

HelpMeSee Joins the National #GivingTuesday Movement To Encourage Spending With A Purpose

HelpMeSee -- a global campaign to cure cataract blindness - has joined #GivingTuesday, with a global ambassador video search contest, a first-of-its-kind effort that will harness the collective powe…

Read the full story

Monday, November 24, 2014 |

Ora-CAC Model Provided Platform for Recent Phase 2 Data for Ocular Therapeutix's OTX-DP in Allergic Conjunctivitis

Ora Inc. announced that its Conjunctival Allergen Challenge (Ora-CAC) model provided a platform for the successful phase 2 clinical results of sustained-release Dexamethasone (OTX- DP), a drug-eluting…

Read the full story

Monday, November 24, 2014 | Medical Studies

CDC: Improper Contact Lens Care Can Lead to Blindness

Contact lenses - worn by around 38 million Americans - are a popular alternative to wearing glasses. But improper care of contact lenses can cause eye infections like keratitis, which can lead to blin…

Read the full story

Monday, November 24, 2014 | Medical Studies

Artificial Retina Could Someday Help Restore Vision

The loss of eyesight, often caused by retinal degeneration, is a life-altering health issue for many people, especially as they age. But a new development toward a prosthetic retina could help counter…

Read the full story

Friday, November 21, 2014 | Earnings & Financials, Allergan, Valeant Ophthalmics

Valeant Slashes Stake in Allergan After Losing Bid

Valeant Pharmaceuticals International said it cut its stake in Allergan to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Man…

Read the full story

Friday, November 21, 2014 | Medical Studies

Telemedicine Screening for Diabetic Retinopathy Finds Condition in 1 of 5 Patients

A telemedicine program to screen for diabetic retinopathy (a leading cause of blindness) at urban clinics and a pharmacy predominantly serving racial/ethnic minority and uninsured patients with diabet…

Read the full story
Load More

Advertisement

 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $26.95  -1.06% 
 Akorn, Inc. $39.11  2.81% 
 Alimera Sciences, Inc. $6.00  3.63% 
 Allergan, Inc. $212.96  0.41% 
 Avalanche $40.15  3.79% 
 Bayer $147.39  0.31% 
 Can-Fite Biopharma $4.04  2.54% 
 Carl Zeiss Meditec $21.97  -2.14% 
 Cooper Companies, Inc. $167.43  0.47% 
 Escalon Medical Corp. $1.41  0.00% 
 Essilor International $110.50  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.47  4.44% 
 InSite Vision, Inc. $0.22  -10.04% 
 IRIDEX Corporation $8.39  -0.59% 
 Johnson & Johnson $107.04  0.32% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $52.61  -0.68% 
 Merck & Company, Inc. $59.74  0.67% 
 NicOx $2.05  -0.49% 
 NovaBay Pharmaceuticals, Inc. $0.71  1.46% 
 Novartis AG Common Stock $95.62  0.61% 
 Ocular Therapeutix $17.38  -4.45% 
 Ophthotech Corporation $42.50  0.40% 
 Quantel $3.14  -1.57% 
 Regeneron $414.60  0.39% 
 Roche $37.36  0.40% 
 STAAR Surgical Company $9.24  -1.91% 
 TearLab Corporation $2.91  0.34% 
 Thrombogenics $8.60  0.00% 
 Topcon Corporation $23.40  0.00% 
 Valeant Pharmaceuticals $144.61  -0.10% 
 Xoma $5.44  -1.45%